RNAC R&D Expense Growth
Cartesian Therapeutics Inc · R&D Expense Growth
RNAC R&D Expense Growth
Latest reported28.66%period ending
RNAC FY R&D Growth (YoY) (0.00% → 28.66%)
Latest values, visible window
High-resolution chart · PNG
RNAC r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 28.6642% | |
| -36.7036% | |
| -1.5433% | |
| 5.2971% | |
| 26.1095% | |
| 27.518% | |
| -10.3676% | |
| 5.584% | |
| 52.0605% | |
| 29.2515% | |
| 119.1493% | |
| 0% |